Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods
Open Access
- 23 September 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (12), 2127-2133
- https://doi.org/10.1182/blood-2010-03-276691
Abstract
Drug-induced immune thrombocytopenia (DITP) is often suspected in patients with acute thrombocytopenia unexplained by other causes, but documenting tThis publication has 30 references indexed in Scilit:
- Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages*European Journal of Haematology, 2010
- The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsAmerican Journal of Hematology, 2010
- Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and managementJournal of Thrombosis and Haemostasis, 2009
- Drug-Induced ThrombocytopeniaDrug Safety, 2009
- Platelet Measurements versus Discharge Diagnoses for Identification of Patients with Potential Drug-Induced ThrombocytopeniaDrug Safety, 2009
- Drug-Induced Immune ThrombocytopeniaThe New England Journal of Medicine, 2007
- Heparin-Induced ThrombocytopeniaThe New England Journal of Medicine, 2006
- Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodiesBlood, 2006
- The role of data mining in pharmacovigilanceExpert Opinion on Drug Safety, 2005
- Using MedDRADrug Safety, 2004